• 2016-4-960

    What is a dermatologic surgeon?

    Part of a progressive medical subspecialty, ASDS member dermatologists perform medically necessary and cosmetic procedures to improve the health, function and beauty of skin through every stage of life.

  • 2016-3-960

    From forehead furrows to frown lines…

    Performing more than 5 million cosmetic procedures each year, ASDS member dermatologists offer many treatments that are less intense, safer and have quicker recovery times than ever before.

  • 2016-2-960

    3 million Americans are diagnosed with skin cancer every year

    Any suspicious new growths or changes should be examined by a dermatologist immediately. ASDS member dermatologists are trained to select the best treatment choice based on the individual patient.

  • 2016-1-960

    From excess fat to wrinkles…

    Offering a range of office-based cosmetic procedures, ASDS member dermatologists can select the appropriate treatment choice to meet your individual goals.

+ / -
Article to be sent via email:

To email(s):
(use commas to separate multiple addresses)
  (use commas to separate multiple addresses)
Your name:
Your email address:
Add a Message:

In This Section

Cutting Edge Research Grant Program (CERG)


2018 Cutting Edge Research Grants will be accepted March 1 - July 9, 2018. Up to $100,000 in grants will be awarded in amounts up to $20,000 per recipient in order to stimulate a broad scope of research relevant to dermatologic surgeons and the dermatology specialty at large. Awards will be announced at the ASDS Annual Meeting, Oct. 11 - 14, 2018, in Phoenix.

Board-directed research

ASDS has taken a proactive approach in positively affecting the future of the specialty of dermatologic surgery by recommending research on Board-directed topics. Board-directed research data is intended to help promote dermatologic surgeons as innovators, foster public awareness of dermatologic surgeons as experts, support ASDS positions on patient safely and regulatory issues, and more. Evidence-based and comparative effectiveness research is called for as well. By facilitating research in specific areas, ASDS will be able to further position itself as a catalyst for key findings in dermatologic surgery, and you can play an integral role.


The ASDS Research Work Group encourages submission of well-conceived research projects that stimulate the advancement of the practice of dermatologic surgery, the invention of new technologies or that document the outstanding and high volume work of dermatologic surgeons. ASDS members are specifically encouraged to submit proposals in the areas of depth of training, scope of practice, safety and efficacy as well as research with specific relevance in:

Eligibility and Guidelines  


This is a competitive award program for research projects. Multiple applications from the same institution/practice may be submitted; however, only one application per institution/practice may potentially be accepted.The principal investigator must be an ASDS member. The research topic must be clinically or socioeconomically oriented to dermatologic surgery. See Board-Directed research topics. Research must be conducted in the United States or Canada and with sponsorship by a department or division of dermatology or other independent dermatologic-related oversight group or organization.The applicant/principal investigator must be physically and intellectually capable of performing the work.The applicant/principal investigator must be sure his/her institution or grant administrator approves him/her to accept the grant prior to submitting the application  

The Cutting Edge Research Grant (CERG) program is supported by generous contributions to the ASDS Dermasurgery Advancement Fund by ASDS members and industry partners. 

For more information, contact ASDS at 847-956-0900. 

2017 CERG winners

Grant recipients for 2017 and their research projects include:

  • Juliet F. Gibson, MD (UT Southwestern, Dallas, TX): Medical Spas in the United States: medical oversight, physician and patient perceptions, and associated litigation.*
  • Jeffrey F. Scott, MD (University Hospitals Cleveland Medical Center, OH): A skin cancer risk model for hematopoietic stem cell transplant recipients.*
  • Jeremy R. Etzkorn, MD (University of Pennsylvania, Philadelphia, PA): Evaluation of patient preferences for skin cancer treatment using choice-based conjoint analysis.*
  • Wesley Yu, MD (University of California, San Francisco, CA): Validation of the English Basal and Squamous Cell Carcinoma Quality of Life (BaSQoL) Questionnaire and Application to Dermatologic Surgery.*
  • Eric Sorenson, MD (UCLA Division of Dermatology, Los Angeles, CA) Early Treatment with Microneedling for Surgical Scars.*
  • Thomas J. Knackstedt, MD (Cleveland Clinic Foundation, Cleveland, OH): The Utility of Radiologic Imaging and Prognostic Significance of American Joint Committee on Cancer (AJCC) Pathologic (T) Staging in Squamous Cell Carcinoma of the Nail Apparatus.
  • Bassel Mahmoud, MD, PhD (University of Massachusetts Medical School, Worcester, MA): Fractional versus ablative Er:YAG laser in melanocyte transplantation surgery, a prospective randomized study with an objective evaluation.
  • Diana Bolotin, MD (The University of Chicago, IL): The Impact of Drug Compounding Regulations on Dermatologic Practice.*

* denotes Board-directed research topics

Render 960px View
Render 768px View
Render 480px View
Render 320px View